These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
898 related articles for article (PubMed ID: 17400194)
1. DNA interactions of new cytotoxic tetrafunctional dinuclear platinum complex trans,trans-[{PtCl2(NH3)}2(piperazine)]. Brabec V; Christofis P; Slámová M; Kostrhunová H; Nováková O; Najajreh Y; Gibson D; Kaspárková J Biochem Pharmacol; 2007 Jun; 73(12):1887-900. PubMed ID: 17400194 [TBL] [Abstract][Full Text] [Related]
2. DNA binding mode of the cis and trans geometries of new antitumor nonclassical platinum complexes containing piperidine, piperazine, or 4-picoline ligand in cell-free media. Relations to their activity in cancer cell lines. Kasparkova J; Marini V; Najajreh Y; Gibson D; Brabec V Biochemistry; 2003 May; 42(20):6321-32. PubMed ID: 12755637 [TBL] [Abstract][Full Text] [Related]
3. DNA binding by antitumor trans-[PtCl2(NH3)(thiazole)]. Protein recognition and nucleotide excision repair of monofunctional adducts. Kasparkova J; Novakova O; Farrell N; Brabec V Biochemistry; 2003 Jan; 42(3):792-800. PubMed ID: 12534292 [TBL] [Abstract][Full Text] [Related]
4. Effect of the geometry of the central coordination sphere in antitumor trinuclear platinum complexes on DNA binding. Kasparkova J; Vrana O; Farrell N; Brabec V J Inorg Biochem; 2004 Oct; 98(10):1560-9. PubMed ID: 15458817 [TBL] [Abstract][Full Text] [Related]
5. Effect of geometric isomerism in dinuclear platinum antitumor complexes on DNA interstrand cross-linking. Kaspárková J; Nováková O; Vrána O; Farrell N; Brabec V Biochemistry; 1999 Aug; 38(34):10997-1005. PubMed ID: 10460154 [TBL] [Abstract][Full Text] [Related]
6. Effects of a piperidine ligand on DNA modification by antitumor cisplatin analogues. Kasparkova J; Novakova O; Najajreh Y; Gibson D; Perez JM; Brabec V Chem Res Toxicol; 2003 Nov; 16(11):1424-32. PubMed ID: 14615968 [TBL] [Abstract][Full Text] [Related]
7. DNA cross-linking patterns induced by an antitumor-active trinuclear platinum complex and comparison with its dinuclear analogue. Zhu J; Zhao Y; Zhu Y; Wu Z; Lin M; He W; Wang Y; Chen G; Dong L; Zhang J; Lu Y; Guo Z Chemistry; 2009; 15(21):5245-53. PubMed ID: 19350599 [TBL] [Abstract][Full Text] [Related]
8. The role of bridging ligands in determining DNA-binding ability and cross-linking patterns of dinuclear platinum(II) antitumour complexes. Zhu J; Lin M; Fan D; Wu Z; Chen Y; Zhang J; Lu Y; Guo Z Dalton Trans; 2009 Dec; (48):10889-95. PubMed ID: 20023919 [TBL] [Abstract][Full Text] [Related]
9. Activation of the trans geometry in platinum antitumor complexes: a survey of the cytotoxicity of trans complexes containing planar ligands in murine L1210 and human tumor panels and studies on their mechanism of action. Farrell N; Kelland LR; Roberts JD; Van Beusichem M Cancer Res; 1992 Sep; 52(18):5065-72. PubMed ID: 1516063 [TBL] [Abstract][Full Text] [Related]
10. Activation of trans geometry in bifunctional mononuclear platinum complexes by a piperidine ligand. Mechanistic studies on antitumor action. Kasparkova J; Novakova O; Marini V; Najajreh Y; Gibson D; Perez JM; Brabec V J Biol Chem; 2003 Nov; 278(48):47516-25. PubMed ID: 12970368 [TBL] [Abstract][Full Text] [Related]
11. Biophysical analysis of natural, double-helical DNA modified by a dinuclear platinum(II) organometallic compound in a cell-free medium. Marini V; Kasparkova J; Novakova O; Monsú Scolaro L; Romeo R; Brabec V J Biol Inorg Chem; 2002 Sep; 7(7-8):725-34. PubMed ID: 12203009 [TBL] [Abstract][Full Text] [Related]
12. Structural characterization and DNA interactions of new cytotoxic transplatin analogues containing one planar and one nonplanar heterocyclic amine ligand. Najajreh Y; Kasparkova J; Marini V; Gibson D; Brabec V J Biol Inorg Chem; 2005 Nov; 10(7):722-31. PubMed ID: 16208494 [TBL] [Abstract][Full Text] [Related]
13. Mechanistic insights into antitumor effects of new dinuclear cis Pt(II) complexes containing aromatic linkers. Zerzankova L; Kostrhunova H; Vojtiskova M; Novakova O; Suchankova T; Lin M; Guo Z; Kasparkova J; Brabec V Biochem Pharmacol; 2010 Aug; 80(3):344-51. PubMed ID: 20399754 [TBL] [Abstract][Full Text] [Related]
15. Unique properties of DNA interstrand cross-links of antitumor oxaliplatin and the effect of chirality of the carrier ligand. Kasparkova J; Vojtiskova M; Natile G; Brabec V Chemistry; 2008; 14(4):1330-41. PubMed ID: 18022972 [TBL] [Abstract][Full Text] [Related]
17. The induction of lysis in lysogenic strains of Escherichia coli by a new antitumor transplatin derivative and its DNA interactions. Brabec V; Pracharova J; Novakova O; Gibson D; Kasparkova J Dalton Trans; 2015 Feb; 44(8):3573-82. PubMed ID: 25406573 [TBL] [Abstract][Full Text] [Related]
18. Cisplatin adducts on a GGG sequence within a DNA duplex studied by NMR spectroscopy and molecular dynamics simulations. Téletchéa S; Skauge T; Sletten E; Kozelka J Chemistry; 2009 Nov; 15(45):12320-37. PubMed ID: 19813235 [TBL] [Abstract][Full Text] [Related]
19. Reversion of structure-activity relationships of antitumor platinum complexes by acetoxime but not hydroxylamine ligands. Zorbas-Seifried S; Jakupec MA; Kukushkin NV; Groessl M; Hartinger CG; Semenova O; Zorbas H; Kukushkin VY; Keppler BK Mol Pharmacol; 2007 Jan; 71(1):357-65. PubMed ID: 17050805 [TBL] [Abstract][Full Text] [Related]
20. Site-specific d(GpG) intrastrand cross-links formed by dinuclear platinum complexes. Bending and NMR studies. Kaspárková J; Mellish KJ; Qu Y; Brabec V; Farrell N Biochemistry; 1996 Dec; 35(51):16705-13. PubMed ID: 8988007 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]